New Data Finds AstraZeneca Booster Generates Higher Antibodies Against Omicron

Related Articles

China Locks Down City Of 9 Million As Covid Cases Increase

March 11, 2022

Africa CDC Signs MOU With Pfizer To Supply COVID-19 Pills

March 10, 2022

From Belgrade Airport Novak Djokovic Returns After Being Deported Over His Unvaccinated Status

January 17, 2022

Make COVID-19 Vaccination Compulsory For State Workers — NPHCDA Tells Governors

January 10, 2022

AstraZeneca said on Thursday January 13, preliminary data from a trial it conducted on its COVID-19 shot, Vaxzevria, showed it generated a higher antibody response against the Omicron variant and others, including Beta, Delta, Alpha and Gamma, when given as a third booster dose.